Tech IPOs, public-market debuts, and what each one means for the exit environment.
Six companies priced IPOs on July 20 alone -- from Jersey Mike's $7.9B consumer offering to Csquare's data-center debut -- the clearest evidence yet that 2026's IPO reopening extends well past AI-branded listings.
Jul 20, 2026General Fusion became the first publicly traded pure-play fusion energy company on July 13, a milestone landing as private fusion funding surges to $4.5 billion over the past year.
Jul 20, 2026DeepSeek is in talks to raise at a $71 billion pre-money valuation ahead of a targeted Shanghai STAR Market listing, weeks after its first-ever outside funding round -- a test case for how China's AI IPO pipeline prices against US frontier labs.
Jul 20, 2026Anthropic is targeting an October 2026 Nasdaq listing at a $965 billion valuation with Goldman Sachs and Morgan Stanley leading -- racing to go public first now that OpenAI has pushed its own IPO target from fall 2026 to 2027.
Jul 20, 2026SpaceX went public at a $1.77 trillion valuation in the largest IPO ever, peaked above $225, and now trades close to 39% below that high near its original $135 offering price.
Jul 20, 2026Jersey Mike's kicked off its IPO roadshow targeting up to a $7.94 billion valuation, offering 43.5 million shares at $21-25 apiece to raise as much as $1.09 billion in one of the largest consumer-brand listings of the year.
Jul 20, 2026Mega-cap AI-infrastructure listings are trading like risk assets -- SpaceX down 42% from its post-IPO peak, Csquare pricing below range -- while a wave of micro-cap biotech S-1s from NuvOx and Valion Bio moves ahead on its own clinical calendar, unaffected.
Jul 19, 2026Moonshot AI has told investors it plans to list in Hong Kong within six months at a valuation above $30 billion, accelerating its IPO timeline after Kimi K3 -- a 2.8-trillion-parameter open-weight model -- matched frontier US labs and briefly wiped hundreds.
Jul 19, 2026China's largest DRAM maker CXMT priced an $8.6 billion Shanghai STAR Market IPO -- Asia's biggest listing of 2026 -- with institutional demand of roughly 500 times the shares on offer, though oversubscription ran lower than recent Chinese tech IPOs amid a.
Jul 19, 2026Value Add Pulse analysis: Databricks tripled its valuation to $188B in 19 months without a single public trading day, making it the clearest test of whether private AI marks survive contact with public markets.
Jul 18, 2026Value Add Pulse analysis: SpaceX's median analyst target implies a 105x revenue multiple even after a 42% post-IPO decline, a comp every AI-adjacent IPO hopeful will now be measured against.
Jul 18, 2026Eighteen banks issued SpaceX targets as high as $800, but the stock has fallen ~42% from its post-IPO peak and now trades near its $135 offer price, a gap that looks like herd behavior, not analysis.
Jul 18, 2026Valion Bio filed a preliminary prospectus for common stock, pre-funded warrants and common warrants, the latest in a cluster of biotech S-1 filings reaching the SEC in mid-July even as tech-sector IPO sentiment cooled.
Jul 17, 2026Tucson-based NuvOx Therapeutics filed an S-1 with the SEC, joining a wave of small biopharma companies testing public-market appetite even as broader tech and AI-infrastructure equities had a rough week.
Jul 17, 2026Apple's trade-secrets lawsuit against OpenAI, alleging its hardware chief directed former Apple staff to bring 'actual parts' to interviews, has already cut Wall Street's odds of a 2026 OpenAI IPO from roughly 22% to 18.5%.
Jul 17, 2026Value Add Pulse analysis: Csquare's soft debut, Standard Nuclear's downsized listing, SpaceX's Starship setback and Alphabet's Gemini-delay selloff landed within 48 hours, showing markets are pricing AI-infra execution risk in real time.
Jul 17, 2026Newcomer's weekly analysis asks whether 2026's red-hot IPO window can survive SpaceX's post-listing stock collapse and a broader volatility spike, with several AI-adjacent companies still queued to list this year.
Jul 17, 2026A dozen new SEC S-1 and S-1/A filings this week, dominated by small biotech and biopharma names, show a steady drip of micro-cap public offerings continuing well below the AI-mega-cap headlines dominating the IPO conversation.
Jul 17, 2026SpaceX shares fell further in premarket trading after a Starship test flight was aborted when several engines failed to start, adding a fresh operational setback on top of the stock's already-below-issue-price slide.
Jul 17, 2026Seven companies spanning biotech, fintech, AI and battery materials filed IPO registration paperwork with the SEC within days of each other, a broad-based cluster that extends the sustained widening of 2026's listing pipeline.
Jul 16, 2026Brookfield-backed data center provider Csquare priced its IPO at $21 a share, below its marketed range, and opened down about 3% at $20.90, a soft debut that signals investor caution toward new data-center listings despite AI-driven demand.
Jul 16, 2026Value Add Pulse analysis: the mix of filings landing in mid-July 2026 -- SPAC revival, sustained biotech S-1s, mega-cap AI IPO prep and a wobbling SpaceX debut -- shows a pipeline broadening in kind, not just size.
Jul 16, 2026TRISO fuel maker Standard Nuclear began trading on the NYSE under ticker STDN after slashing its IPO size by 58% to $150 million on the eve of pricing, a live early test of how public markets value pre-revenue nuclear-fuel suppliers.
Jul 16, 2026Data-center operator Csquare priced its IPO $2 below range at $21 a share, raising $1.05 billion, and slipped further on its NYSE debut -- a soft landing for the year's newest bet on AI-driven data-center demand.
Jul 16, 2026SpaceX shares fell below their $135 IPO price for the first time, erasing enough of Elon Musk's paper wealth to end his trillionaire status.
Jul 16, 2026TRISO fuel maker Standard Nuclear cut its IPO to $150 million from a planned $355.88 million on the eve of pricing, a rare down-sizing that signals soft investor demand even inside the hot nuclear-fuel supply-chain theme.
Jul 15, 2026SpaceX stock traded below its $135 IPO price for the first time, a notable early test for one of the most anticipated public listings in recent market history.
Jul 15, 2026Jaguar Health and Vogenx both filed S-1 paperwork with the SEC, adding to a biotech IPO queue that's grown steadily through 2026 as public-market appetite for clinical-stage listings recovers.
Jul 15, 2026Banzai International, FreeCast, authID and Churchill Capital Corp XIII all filed IPO or SPAC-related paperwork with the SEC the same day, a notable cluster in an otherwise quiet software-listing environment.
Jul 15, 2026Anthropic is moving closer to a public listing, with bankers reportedly lining up investor meetings, a step that would make it one of the largest AI IPOs alongside OpenAI's own expected debut.
Jul 15, 2026Stripe's acquisition pace has accelerated meaningfully, with nothing rivaling its reported interest in a roughly $53 billion PayPal-related deal, a scale of ambition unusual for a still-private fintech giant.
Jul 15, 2026Standard Nuclear filed an amended S-1/A refining terms for its planned NYSE listing to fund its small modular reactor buildout, a sign underwriters are finalizing roadshow pricing.
Jul 15, 2026Two SPAC vehicles, Crestone Strategic Capital and Material Resource Acquisition Corp, both progressed toward listing this week, a quiet sign the blank-check market is testing itself again.
Jul 14, 2026Morgan Stanley filed amended S-1s for both a Morgan Stanley Ethereum Trust and a Morgan Stanley Solana Trust, extending the spot-Bitcoin-ETF playbook to the next tier of large-cap tokens.
Jul 14, 2026Braveheart Bio and Attovia Therapeutics both filed S-1s the same week, adding two names to 2026's biotech IPO pipeline amid the strongest H1 biotech venture funding since 2022.
Jul 14, 2026Anthropic's confidential S-1 and $965 billion valuation sit against a backdrop where this year's actual IPO winners -- SK Hynix, Csquare, Standard Nuclear -- have all been physical infrastructure, not software-first AI labs.
Jul 14, 2026SK Hynix, Csquare, Standard Nuclear and Meta's $50B Louisiana buildout keep winning capital while pure application-layer software IPOs stay scarce -- a gap that's now wide enough to be the real 2026 IPO story.
Jul 14, 2026Plaid is weighing a US IPO after reaching an $8 billion valuation, still well below its 2021 peak of $13.4 billion, a signal of how selectively fintech valuations are recovering as physical AI infrastructure dominates IPO attention.
Jul 14, 2026DeepSeek is reportedly in talks to raise $1.5 billion in private funding as a step toward an eventual IPO, following Goldman Sachs naming it a preferred Chinese AI model.
Jul 14, 2026Legacy data-storage company Quantum Corp filed a new S-1 with the SEC, a notable re-listing move as AI-driven data growth renews demand for storage infrastructure.
Jul 13, 2026SPACs priced 55 IPOs raising $9.8 billion in Q2 2026 alone, and a fresh wave of merger announcements -- from healthcare to energy to biotech -- shows the vehicle finding real footing again after its 2022-era collapse.
Jul 13, 2026Tarsier Pharma's ~$45 million NYSE American debut shows biotech's IPO window remains open in 2026 -- but only for companies with genuinely differentiated, late-stage pipelines, not broad speculative interest.
Jul 13, 2026SK Hynix's 13% first-day pop is the freshest data point ahead of a much bigger test: OpenAI and Anthropic are both racing toward IPOs that could value the two labs at a combined $2 trillion or more.
Jul 13, 2026LimX Dynamics and Unitree are rushing toward IPOs as Chinese humanoid-robotics companies treat a public listing as close to mandatory, following LimX's $200 million pre-IPO round at a $2.21 billion valuation.
Jul 13, 2026Standard Nuclear plans to list on the NYSE this week, offering 18.25 million shares at $18-$21 to raise roughly $356 million at a $3.3 billion valuation, funding its small modular reactor buildout.
Jul 13, 2026Csquare, a data-center operator, is set to list on the NYSE this week offering 50 million shares at $23-$27, targeting roughly $1.25 billion at the midpoint -- one of two infrastructure IPOs headlining this week's calendar.
Jul 13, 2026SK Hynix's ADRs began trading under their permanent ticker SKHY on Monday, days after the memory-chip giant's $26.5 billion Nasdaq debut -- the largest-ever US listing by a non-American company -- popped 13% on its first day.
Jul 13, 2026Value Add Pulse analysis: the largest, best-received 2026 IPOs and pre-IPO windfalls have overwhelmingly gone to the physical and financial infrastructure underneath AI, not to application-layer companies riding on top of it.
Jul 12, 2026James Murdoch's roughly $120 million of pre-IPO SpaceX stock, bought in 2019 and 2020 via Lupa Systems, could now be worth as much as $7.4 billion following SpaceX's public listing, Pitchbook analysis shows.
Jul 12, 2026US IPO proceeds hit roughly $115.6 billion in H1 2026 on a handful of AI and chip mega-deals, but Fortune reports strategists expect H2 to broaden into manufacturing, defense and energy listings.
Jul 11, 2026SK Hynix's ADRs priced at $149 and closed up nearly 13% on their Nasdaq debut, raising $26.5 billion in the largest first-time U.S. listing by a foreign company on record.
Jul 10, 2026SK Hynix priced 177.9 million ADRs at $149 each to raise $26.5 billion on Nasdaq, topping Alibaba's 2014 debut as the largest US listing ever by a foreign company, and popped 14% at the open.
Jul 10, 2026Holtec Nuclear Corp, which owns and is restarting Michigan's 800 MW Palisades plant and leads spent-fuel storage, filed for a Nasdaq listing to fund its SMR-300 small modular reactor rollout.
Jul 10, 2026Apnimed, a Shionogi-backed clinical-stage biotech, filed for a Nasdaq IPO under ticker APMD as its lead drug candidate Oxnimbi -- the first investigational oral pill for obstructive sleep apnea -- awaits an FDA decision expected in Q1 2027.
Jul 10, 2026AI infrastructure company Corvex is going public through a reverse merger with public shell Movano Inc., with Corvex shareholders projected to own about 94.8% of the combined entity.
Jul 10, 2026Healthcare Triangle filed an S-1 registering 28 million shares for resale by Hudson Global Ventures, giving the Nasdaq-listed healthcare-cloud company access to up to $50 million in gross proceeds through an equity line of credit.
Jul 10, 2026Scribe Therapeutics, the CRISPR biotech co-founded by Nobel laureate Jennifer Doudna, amended its S-1 to list on Nasdaq under ticker SCTX, backed by more than $180 million in Sanofi and Eli Lilly partnership payments.
Jul 10, 2026Laser Photonics Corp, a Nasdaq-listed industrial laser-cleaning maker, filed its third S-1 of 2026 on July 10, continuing a pattern of registering shares tied to inducement and placement-agent warrants.
Jul 10, 2026Decoy Therapeutics filed its second S-1 in a month tied to a private placement that could deliver up to $21 million in milestone-based warrant proceeds contingent on trial results and shareholder approval.
Jul 10, 2026iPower Inc, a Rancho Cucamonga-based consumer products company trading under "IPW," filed a new Form S-1 on July 10, its second such registration of 2026 after an earlier S-1/A in January.
Jul 10, 2026Avalanche Treasury Corp, whose AVAT stock has fallen 73% since its Nasdaq debut via SPAC merger, filed a new S-1 as it flags crypto losses and warns it may not survive without additional financing.
Jul 10, 2026Universal Safety Products filed a Form S-1 for up to 10.6 million shares on the same day it warned of a substantial sales and gross-profit decline and an expected net loss for the year ended March 31, 2026.
Jul 10, 2026NeuroSpectrum Insights, formerly Autism Diagnostic Technologies, filed its fifth S-1/A amendment since January, the latest step in a lengthy SEC review process for its planned public offering.
Jul 10, 2026Chinese chipmaker Nexchip Semiconductor priced its Hong Kong listing at HK$32.30 per share, the top of its range, raising roughly HK$6.98 billion ($890 million) as it pursues a dual Shanghai-Hong Kong listing amid a booming HK IPO market.
Jul 9, 2026GridAI Technologies, formerly biopharma company Entero Therapeutics, filed an amended S-1 registering shares tied to recent PIPE financings as it repositions around energy-orchestration and grid-optimization software for AI datacenters.
Jul 9, 2026Zapata Quantum filed an amended S-1/A registering 56.8 million shares for resale, disclosing ongoing losses and going-concern risk despite a recent $15 million Series D and a return to current SEC reporting status.
Jul 9, 2026Nevada-incorporated Mitesco filed an S-1 to register shares issuable under a new equity line of credit, part of a small-cap financing pattern distinct from this week's AI mega-rounds.
Jul 9, 2026BOA Acquisition Corp II filed to raise up to $200 million in a blank-check IPO targeting real estate and infrastructure, part of a steady 2026 revival in SPAC issuance running well below the AI-mega-deal headlines.
Jul 9, 2026European startups raised $24 billion in Q2 2026, up two-thirds year-over-year, with UK startups alone pulling in more than $10 billion -- the region's third-largest quarter on record.
Jul 9, 2026AEON Biopharma filed a fresh S-1 for a biosimilar program while Mobix Labs amended its filing disclosing a going-concern warning -- a reminder this week's IPO pipeline is mostly small-cap, not AI infrastructure.
Jul 9, 2026Smith Micro Software filed a Form S-1 solely to register the resale of shares underlying previously issued warrants and convertible notes, explicitly stating the filing dilutes no existing shareholders.
Jul 9, 2026Beyond SK Hynix's $28-29 billion Nasdaq debut, this week's US IPO calendar is nearly empty -- a sharp contrast to June's run of SpaceX, Cerebras and Lime, and a sign the pipeline is thinner than headline enthusiasm suggests.
Jul 9, 2026SK Hynix priced its Nasdaq ADS offering at roughly $158 per share on July 9 after a book that was reportedly oversubscribed 7 times, with trading set to begin July 10 under ticker SKHY.
Jul 9, 2026European startups exited $7.2 billion across 172 M&A deals in Q2 2026, with four of the 18 global $1 billion-plus VC-backed acquisitions coming from Europe -- while the region's IPO pipeline stays thin.
Jul 9, 2026Anthropic's $50 billion Series H, split across a ten-investor syndicate plus separate multi-billion tranches from Google and Amazon, shows how mega private rounds are absorbing capital that once would have pushed companies toward an IPO.
Jul 8, 2026A wave of small blank-check filings -- Southern Cross Acquisition II, OceanLight Acquisition and others -- is moving through the SEC this week, even as the large-cap IPO calendar stays nearly empty outside SK Hynix's Nasdaq debut.
Jul 8, 2026Leef Brands, a Vancouver-based cannabis company, filed an S-1 registering more than 81.5 million common shares, joining a wave of smaller companies moving through the SEC pipeline this week.
Jul 8, 2026Wyoming-incorporated Jaovi Inc, based in Costa Rica, filed an S-1 registering 4 million shares at $0.03 each for a total offering of just $120,000 -- illustrating the far end of the small-cap IPO pipeline.
Jul 8, 20262026's IPO market is really two separate markets: trillion-dollar AI infrastructure debuts stacked against a shakier field of traditional listings -- and only one of those two is actually working.
Jul 8, 2026Standard Nuclear disclosed terms for its NYSE IPO on July 7, offering 18.25 million shares at $18-$21 to raise up to $355.9 million and fund expansion of its domestic nuclear-fuel production.
Jul 7, 2026SK Hynix kicked off bookbuilding for a $28.13 billion Nasdaq ADS offering, with cornerstone investors committing up to $7 billion even as its Seoul-listed shares slid 6.7% on dilution concerns.
Jul 7, 2026Standard Nuclear, an Oak Ridge maker of advanced TRISO reactor fuel with a $245 million backlog, filed for an NYSE IPO under ticker STDN as AI-driven power demand accelerates interest in next-generation nuclear supply chains.
Jul 7, 2026From Agility Robotics to Securitize to Elroy Air, 2026's capital-intensive hardware and infrastructure companies are increasingly choosing SPAC mergers over traditional IPOs to reach public markets faster.
Jul 7, 2026A run of 2026 biotech IPOs, led by Parabilis Medicines and Kailera Therapeutics, has broken records once held by Moderna, signaling the biotech public-market window has genuinely reopened after years of caution.
Jul 7, 2026SpaceX has already gone public near a $2 trillion valuation, while Anthropic and OpenAI's confidential IPO filings imply valuations of $965 billion and $852 billion, setting up 2026's biggest test of public-market AI pricing.
Jul 7, 2026Bending Spoons' 40% Nasdaq debut pop to a near-$26 billion valuation, alongside fresh European mega-funds like Kembara's, is reviving confidence that Europe can produce IPO-ready tech companies again.
Jul 7, 2026Edge-AI chipmaker Syntiant disclosed a $26.2 million quarterly net loss on $64.5 million in sales ahead of its Nasdaq listing under ticker SYTN, led by Citigroup, Bank of America and UBS.
Jul 6, 2026Securitize completed its SPAC merger with Cantor Equity Partners II and rang the NYSE closing bell on July 6, becoming the first newly public company to tokenize its own stock on Solana and Avalanche on day one.
Jul 6, 2026SK Hynix, the world's second-largest memory chipmaker and a top supplier of AI-GPU memory to Nvidia, filed to list 177.9 million ADSs on Nasdaq under ticker SKHY, seeking up to $29.4 billion in one of the largest offerings on record.
Jul 6, 2026A wave of new S-1 filings this week -- spanning cybersecurity, biotech, medical devices and SPAC vehicles -- shows a broader IPO pipeline building beneath the mega-cap headlines like Agility Robotics and SK Hynix.
Jul 6, 2026Syntiant, an Intel-backed maker of ultra-low-power AI chips for earbuds and cars with over 100 million units deployed, filed for a Nasdaq IPO under ticker SYTN after posting a $20.9 million Q1 net loss on $64.5 million revenue.
Jul 6, 2026Cycurion, which sells AI-driven cybersecurity to the Department of Defense and Homeland Security with an $80 million backlog, filed for a Nasdaq IPO under ticker CYCU after closing a bolt-on Secuvant acquisition.
Jul 6, 2026Agility Robotics' $2.5B SPAC merger tests whether a humanoid robotics company with real warehouse revenue can avoid the boom-bust volatility that has plagued most SPAC-listed companies over the past several cycles.
Jul 5, 2026Agility Robotics is merging with Churchill Capital Corp XI in the largest capital raise in humanoid robotics history, with $300M+ in booked revenue but a CEO who says home robots are still a decade away.
Jul 5, 2026Swiss healthcare REIT Infracore and German defense-communications firm Smag are both racing toward July listings, adding to a busier-than-expected European IPO calendar even as broader international indices soften.
Jul 5, 2026Secondary markets are pricing Anthropic's confidential IPO filing at $1.05-$1.15 trillion, a premium over its last private round, as revenue growth accelerates ahead of an October Nasdaq target.
Jul 5, 2026OpenAI is reportedly weighing a delay of its IPO to 2027 amid volatile public markets and SpaceX's choppy post-debut trading, a hesitation that could reshape the entire 2026-2027 tech IPO pipeline.
Jul 4, 2026Beyond the SpaceX and Bending Spoons headlines, 2026's tech IPO count is already running about 8% ahead of 2025, with smaller healthcare-data and industrial-tech filers like OneMedNet quietly testing the market.
Jul 4, 2026International IPO indices softened this week even as US listings stayed active, with new SPAC filings targeting AI, quantum computing and Asia-focused deals showing the pipeline still building beneath the volatility.
Jul 4, 2026SpaceX will join the Nasdaq-100 before market open on July 7, just 17 days after its June IPO -- one of the fastest index inclusions on record -- forcing an estimated $4.3B in passive index-fund buying.
Jul 3, 2026IQM, the Finland-based full-stack quantum computing company, went public on Nasdaq July 2 via a SPAC merger with RAAQ at a roughly $1.9 billion valuation, but shares traded below the IPO price for most of the day -- a lukewarm debut IQM's own prospectus.
Jul 2, 2026Jersey Mike's Subs Inc. filed its S-1 for an IPO on July 2, mentioning 'artificial intelligence' or 'AI' 22 times despite being a sandwich-chain franchisor with no AI product offerings, TechCrunch reported the same day.
Jul 2, 2026Hopper agreed to pay $35 million to settle FTC allegations that it used deceptive 'dark patterns' to hide fees and misrepresent the costs and benefits of its 'VIP Support' and 'Price Freeze' services, the agency announced July 2. The settlement follows a pattern of recent FTC crackdowns on hidden-fee practices at Match, StubHub, neobank Dave and Fortnite, and requires Hopper to clearly disclose all fees going forward, though the company says the practices at issue were discontinued in mid-2023, before the FTC's inquiry began.
Jul 2, 2026Scribe Therapeutics filed its S-1 with the SEC on July 2, seeking to list on the Nasdaq Global Market under the ticker 'SCTX.' The clinical-stage biotech, co-founded by CRISPR pioneer and Nobel laureate Dr. Jennifer Doudna, has raised roughly $150 million in equity financing since 2017 and is advancing STX-1150 -- an epigenetic-silencing CRISPR candidate for cardiovascular disease -- through an Australian first-in-human trial, while disclosing only $49.7 million in cash and marketable securities against a $175.1 million accumulated deficit.
Jul 2, 2026Cycurion, a McLean, Virginia-based AI-driven IT cybersecurity and public-sector technology firm, filed a Form S-1 covering nearly 26 million shares for resale, following its completed merger with security services firm Secuvant, which closed June 3, 2026.
Jul 2, 2026Peraso Inc., a fabless semiconductor company building millimeter-wave (mmWave) wireless chips, filed an S-1 on July 2 registering up to 31.75 million shares for resale by Roth Principal Investments under a new Common Stock Purchase Agreement dated June 30 -- an equity line that could provide Peraso up to $25 million in gross proceeds. The filing comes with shares trading at just $0.83 on the Nasdaq Capital Market as of June 29, and Peraso's auditor has flagged substantial doubt about its ability to continue as a going concern.
Jul 2, 2026Bending Spoons surged 40% on its Nasdaq debut in the largest software IPO of 2026, then gave back 8.5% the next trading day, underscoring how volatile even a successful AI-era IPO's first week can be.
Jul 2, 2026Crunchbase News reported July 2 that 32 companies went public above a $1 billion valuation in Q2 2026 and 24 more were acquired at $1 billion-plus valuations totaling a record $113 billion, headlined by SpaceX's $1.77 trillion IPO (raising $75 billion) and.
Jul 2, 2026Scribe Therapeutics filed to raise up to $75 million in a Nasdaq IPO, becoming an early test of public-market appetite for Phase 1 biotechs -- its lead candidate, a CRISPR-based epigenetic therapy targeting PCSK9 to lower LDL cholesterol, is already in a.
Jul 2, 2026Lime, the Uber-backed scooter and e-bike rental company, priced its Nasdaq IPO at $25 per share on June 30 — the midpoint of its $24-$26 range — selling 6.96 million shares to raise $174 million at a $1.6 billion valuation. Shares jumped about 9% in their first hour of trading July 1 under ticker LIME, capping years of on-again, off-again public-listing speculation for the micromobility company.
Jul 1, 2026Milan-based Bending Spoons priced its IPO at $29 per share, raised $1.68 billion, and closed its first trading day up 40% at $40.50, pushing its market cap to $25.7 billion -- more than double its prior $11 billion private valuation -- TechCrunch reported.
Jul 1, 2026Bending Spoons priced its Nasdaq IPO at $29 per share on June 30 — above its $26-$28 marketed range — raising $1.68 billion at an $18.4 billion valuation, then closed its first trading day up roughly 40% near $25.7 billion. The Milan-based company, which buys and revitalizes aging tech brands including AOL, Evernote, Meetup and Vimeo, posted $601 million in Q1 revenue and swung to a $27.4 million profit from a $112 million loss a year earlier.
Jul 1, 2026VenHub Global filed an S-1/A amendment on July 1 as it works toward a direct listing on Nasdaq under ticker VNHB, registering up to 15.5 million shares for sale by existing holders rather than raising new capital. The company builds fully autonomous, AI-driven robotic smart stores, has deployed three to date, and carries an accumulated deficit near $98.8 million with auditors flagging substantial going-concern doubt.
Jul 1, 2026Milan-based Bending Spoons priced its Nasdaq IPO at $29 a share on June 30 — above its marketed $26-$28 range — raising $1.68 billion and valuing the company at roughly $18.4 billion. Shares opened at $31 on July 1, touched an intraday high of $42.50, and closed the session at $40.50, up nearly 40%, making it one of the strongest software IPO debuts of 2026 despite a broader SaaS slowdown.
Jul 1, 2026Shared e-bike and scooter operator Lime listed on Nasdaq on July 1, pricing nearly 7 million shares between $24 and $26, becoming one of the first profitable consumer mobility names to test public markets in 2026.
Jul 1, 2026OneMedNet Corporation, a Minnesota-based healthcare data company, filed a Form S-1 on July 1 registering up to 11.68 million shares of common stock, including up to 8.5 million shares issuable under a Standby Equity Purchase Agreement (SEPA) dated the same day. SEPAs let a public company draw down capital incrementally by selling shares to an investor at its own discretion, a financing structure often used by smaller-cap companies that need flexible access to capital without a traditional follow-on offering.
Jul 1, 2026Actelis Networks filed a new Form S-1 with the SEC on July 1, following an earlier registration statement that went effective in November 2025. The Sunnyvale, California-based company sells hybrid fiber-copper-coax networking equipment for IoT, security and telecom deployments, letting customers deploy fast, secure connectivity over existing copper and coaxial infrastructure without a full fiber rebuild.
Jul 1, 2026Asia AI Group Inc filed a Form S-1 with the SEC on July 1, joining a wave of smaller companies filing AI-branded registration statements even as OpenAI, Anthropic and SpaceX dominate IPO headlines with valuations near or above $1 trillion. The filing adds to a growing list of small-cap AI-named S-1s this year, underscoring how far the AI-IPO enthusiasm has spread beyond the handful of marquee frontier labs getting most investor attention.
Jul 1, 2026Freedom Metals Acquisition Corp filed an S-1/A amendment on July 1, detailing a blank-check company structure targeting acquisitions in the critical metals and mining sector. Sponsor NLC America SPAC 1 LLC and underwriter Cohen & Company Capital Markets have committed to purchase private placement units worth up to roughly $9.1 million if the over-allotment option is exercised in full, positioning the SPAC to hunt for a target in a sector newly critical to both AI data-center buildouts and defense supply chains.
Jul 1, 2026Lime — the world's largest shared micromobility operator, formally Neutron Holdings — priced its Nasdaq IPO at the $25 midpoint on June 30 and begins trading July 1 under ticker LIME, raising roughly $174-182M at a $1.63-1.8B market cap. Uber, which owns a meaningful stake and operates Lime bikes and scooters through its ride-hail app, is a key backer testing whether the scooter category still has a public-market future after Bird's bankruptcy.
Jul 1, 2026QumulusAI filed a seventh S-1/A amendment on July 1 ahead of a planned Nasdaq direct listing, detailing an Atlanta-based GPU-as-a-service business built from the 2022 merger of a blockchain-hosting company and a data-center asset firm, later rebranded after acquiring The Cloud Minders in 2025. The company reported $3.4 million in quarterly revenue against a $5.5 million operating loss, is scaling toward 120 megawatts and up to 90,000 Nvidia B200/B300 GPUs, and disclosed going-concern risk in its filing.
Jul 1, 2026Encore Medical filed an amended S-1 on July 1 ahead of a planned NYSE American listing under ticker EMI, offering 3 million shares at an expected $5.00 each to raise roughly $12.6-14.67 million to fund US clinical trials for its catheter-delivered heart-defect closure device, which has completed more than 35,000 implants outside the United States but has not yet been approved for US sale. Underwriters BofA Securities, Goldman Sachs and Morgan Stanley are jointly leading the offering.
Jul 1, 2026Actelis Networks, the Nasdaq-listed hybrid fiber-coax networking company, filed a Form S-1 on July 1 to re-register shares tied to an amended equity line of credit (ELOC) with White Lion Capital, after 10 million of the 10.6 million shares originally registered for the arrangement in October 2025 remained unsold. The amendment registers up to 15.85 million shares across revised ELOC shares, commitment shares and warrant shares — a dilutive financing structure for a cybersecurity-hardened networking equipment maker, rather than a new IPO.
Jul 1, 2026Factorial Energy completed its business combination with Cartesian Growth Corporation III and began trading on Nasdaq under ticker FAC on June 8, implying about $1.3 billion in equity value and delivering over $100 million in gross proceeds to fund commercialization of its solid-state batteries for defense, data centers, drones, robotics and e-mobility. Stellantis holds a 9.5% stake in the combined company, underscoring continued automaker conviction in solid-state battery technology.
Jun 30, 2026Encore Medical, a structural heart device company developing transcatheter septal occlusion products, filed its latest S-1/A on June 30, targeting an IPO of 3 million shares at an expected $5 per share on NYSE American under ticker EMI. The company's cash balance stood at just $34,619 as of March 31, 2026, underscoring how urgently it needs the offering to fund ongoing US clinical trials.
Jun 30, 2026SeeQC, which builds digital quantum-computing infrastructure, filed a Form S-1 to list on the Nasdaq Global Market under ticker 'SEQC,' paired with a $65 million PIPE financing that values the combined entity at roughly $1 billion. The company integrates superconducting single-flux-quantum logic with cryogenic CMOS to shrink the wiring and heat load of quantum systems -- reporting $4.2 million in 2025 revenue against a $12.2 million net loss.
Jun 29, 2026SunPower filed a Form S-1 with the SEC on June 29, registering shares for resale as the rebuilt residential and small-business solar company steps toward the public markets. Trading under ticker SPWR, the company is pitching an end-to-end offering -- technology platform, financing and high-performance equipment -- in a U.S. solar market reshaped by shifting incentives and consolidation.
Jun 29, 2026Digital quantum computing firm SeeQC filed an S-1 on June 29, becoming one of the first pure-play quantum specialists to file since the 2021 SPAC rush. SeeQC's superconducting chips integrate quantum bits directly with classical control electronics, targeting scalable systems that competitors say require room-scale cabinets today.
Jun 29, 2026Tenon Medical filed an S-1MEF with the SEC on June 29, registering additional shares to support a public offering as the small-cap medical-device company funds the commercialization of its sacroiliac (SI) joint fusion system. The filing is a window into the steady, less-glamorous flow of medtech issuers tapping public markets even as AI and mega-IPOs dominate headlines.
Jun 29, 2026Startup exits worth $1 billion or more were more numerous in Q2 2026 than at any point since the 2021 market peak, according to Crunchbase data -- powered by SpaceX's record IPO (a $2.1 trillion first-day market cap on $75 billion raised), Cerebras's and Quantinuum's debuts, and SpaceX's $60 billion acquisition of Cursor. The quarter signals the long-frozen exit window has decisively reopened for late-stage tech.
Jun 29, 2026Matternet, which bills itself as the world's only FAA type-certified drone-delivery platform, filed a Form S-1 with the SEC, following its May 2026 reverse-merger debut and a ~$33 million private placement. The filing registers shares as the company funds the rollout of its next-generation delivery platform across food, retail and healthcare -- a marker of how the autonomy IPO pipeline is broadening beyond ground robotaxis.
Jun 29, 2026Crunchbase data published June 29 shows venture-backed startup exits valued at $1 billion or more hit their highest count in Q2 2026 since the 2021 market peak, headlined by SpaceX's roughly $2.1 trillion first-day market cap IPO and SpaceX's subsequent $60 billion all-stock acquisition of Cursor — the priciest purchase of a private, venture-backed startup ever, nearly double Google's $32 billion Wiz deal.
Jun 29, 2026AMASS Brands filed a Form S-1 with the SEC on June 29, stepping toward a public listing as a consumer-brands company -- a notable test of whether the reopened IPO window extends beyond AI and deep tech into consumer packaged goods. The filing adds a different flavor to a 2026 pipeline dominated by frontier-tech and infrastructure names.
Jun 29, 2026Exyn Technologies filed an S-1 on June 29 to go public, joining a wave of autonomy and defense-tech companies pursuing 2026 IPOs. Its GPS-denied drone autonomy stack ships into mining, industrial inspection and defense customers — a category directly benefiting from Pentagon's Iran-war-accelerated drone procurement push.
Jun 29, 2026Exyn Technologies, which builds fully autonomous aerial robots for GPS-denied environments like underground mines, filed a Form S-1 with the SEC. The company's drones have achieved Level 4 autonomy -- the highest aerial autonomy demonstrated to date, with onboard mapping and no human pilot -- positioning Exyn in the fast-emerging 'physical AI' category just as governments and investors pour capital into embodied robotics.
Jun 29, 2026Q2 2026 produced the most billion-dollar startup exits since the 2021 boom, led by SpaceX's blockbuster IPO and its record $60 billion purchase of Cursor parent Anysphere, according to Crunchbase data. While exit counts still trail the 2021 peak, the sheer size of deals -- with Anthropic and OpenAI now filing to test the trillion-dollar mark -- is the defining feature of the reopened liquidity window.
Jun 29, 2026KIDZ AI Inc. (Nasdaq: KIDZ), the AI-education company formerly known as Classover Holdings, filed a Form S-1 with the SEC as it pivots from live online enrichment classes for kids toward AI-powered learning systems -- and, notably, AI compute infrastructure and GPU cloud. The rebrand-and-refile captures both the edtech-AI wave and the 2026 trend of small caps chasing the AI-infrastructure story.
Jun 26, 2026Ionic Digital filed a Form S-1 on June 26 to list on Nasdaq, joining a fresh wave of bitcoin-mining IPOs riding a record-high BTC price and post-halving miner economics. The company operates data-center-scale hosted mining infrastructure and is pivoting portions of capacity toward AI compute contracts.
Jun 26, 2026TEN Holdings (Nasdaq: XHLD), the parent of event production and broadcasting firm Ten Events, filed an S-1MEF with the SEC and priced a $7.5 million offering of 7.5 million shares at $1.00 each, with WestPark Capital as sole placement agent. The deal is a small but telling sign that capital-markets activity is reaching well down the cap-size spectrum, not just the marquee AI and biotech names.
Jun 26, 2026Clinical-stage biotech Jupiter Neurosciences (Nasdaq: JUNS) filed a Form S-1 with the SEC to register fresh capital as it advances its lead candidate JOTROL, a proprietary resveratrol platform targeting rare and neuroinflammatory CNS disorders and, increasingly, longevity. The filing adds another central-nervous-system name to a 2026 biotech pipeline that keeps widening alongside AI and chips.
Jun 26, 2026QumulusAI filed its latest S-1/A amendment with the SEC on June 26, continuing a string of amendments dating back to February as it works toward a Nasdaq listing. The company delivers rapid-deployment, GPU-powered cloud infrastructure targeted at small and mid-market AI teams — machine learning groups, AI infrastructure startups and research institutions — that large hyperscalers often underserve or price out.
Jun 26, 2026Oncology biotech Akari Therapeutics (Nasdaq: AKTX) filed a Form S-1/A with the SEC to register capital as it advances AKTX-101, a TROP2-targeting antibody-drug conjugate built on its proprietary PH1 payload platform. The filing adds another clinical-stage cancer name to a 2026 capital-markets pipeline that biotech is increasingly populating alongside AI and chips.
Jun 26, 2026Acquirers have spent at least $119.8 billion buying US startups so far in 2026, on pace to beat 2025's record, with SpaceX's $60 billion purchase of Cursor parent Anysphere -- the largest startup acquisition ever -- leading the charge. Biotech made up half the top-10 deals, signaling that the exit window has reopened broadly, not just for AI.
Jun 25, 2026Track Group, which designs location-tracking devices and the software and analytics behind them, filed a Form S-1 with the SEC. The filing adds a govtech and public-safety hardware name to a 2026 IPO pipeline dominated by AI labs and semiconductors -- a reminder that the listing window is broadening to less glamorous, cash-generating niches.
Jun 24, 2026Vivakor, a Nasdaq-listed integrated energy transportation, storage and crude-logistics operator, filed an amended Form S-1 with the SEC. The filing -- coming as crude-oil volatility lifts demand for midstream infrastructure -- highlights how the IPO and registration pipeline extends well beyond tech into the physical energy economy underpinning the AI buildout.
Jun 24, 2026iSpecimen, which operates an online marketplace connecting medical researchers with human biological specimens, filed a Form S-1 with the SEC. The filing adds a health-data and life-sciences infrastructure name to a 2026 IPO pipeline that has skewed heavily toward AI labs and semiconductors.
Jun 24, 2026Liminatus Pharma, a clinical-stage biotech developing cancer immunotherapies, filed a Form S-1 with the SEC for an IPO. The filing is a sign of life in the long-dormant biotech IPO market, which has lagged the tech-led reopening.
Jun 23, 2026Spin AI, which builds AI-driven security and data-protection software for SaaS applications, filed a Form S-1 with the SEC to go public. The filing adds an enterprise-security name to a widening IPO pipeline, riding demand for tools that protect the sprawling stack of cloud apps companies now run.
Jun 23, 2026Ambiq Micro, the ultra-low-power semiconductor company whose chips power wearables and edge-AI devices, filed an S-1MEF with the SEC -- a registration that companies submit immediately before an IPO prices. The filing signals Ambiq is in the final stretch toward going public as appetite for chip and edge-AI names returns.
Jun 23, 2026Nauticus Robotics, which builds autonomous subsea robots and the AI software that runs them, filed an amended S-1 (S-1/A) with the SEC. The filing rides a wave of investor appetite for autonomous maritime and defense systems, the same demand fueling private giants like Saronic.
Jun 22, 2026Austin-based Ambiq Micro filed an S-1 on June 22 to list on the NYSE, marking the largest ultra-low-power AI chip IPO filing of 2026. Ambiq's Apollo family powers ~200 million shipped smartwatches, wearables and IoT sensors and is a leading candidate to define on-device AI silicon in consumer electronics.
Jun 22, 2026VenHub Global, which builds fully autonomous, AI-powered smart stores, filed a Form S-1 with the SEC to go public. The filing brings a physical-AI retail automation play to the IPO pipeline, betting that robotic, self-operating storefronts can reshape convenience retail.
Jun 22, 2026Austin-based Ambiq Micro filed its S-1 to go public, pitching investors on ultra-low-power semiconductors for AI at the edge. Its proprietary SPOT technology claims to run chips at roughly a tenth of normal voltage for up to 80% energy savings -- a timely story as AI's power appetite dominates the narrative.
Jun 22, 2026Neutron Holdings, the parent of micromobility operator Lime, has filed to go public on the Nasdaq under the ticker 'LIME,' targeting roughly $200 million in proceeds at about a $1.8 billion valuation. Lime crossed $886 million in revenue in 2025 with positive free cash flow, but warned of 'substantial doubt' about continuing as a going concern without the raise.
Jun 22, 2026Go, Japan's dominant ride-hailing app, jumped 21% in its Tokyo debut after a 25x-oversubscribed ¥88.6 billion offering -- the country's largest IPO of 2026 -- and is now steering the proceeds toward Waymo-powered robotaxis and acquisitions. It's a rare profitable, category-leading tech listing, and a signal that the IPO thaw has gone global.
Jun 19, 2026Go Inc., Japan's dominant ride-hailing app, raised about $580 million in the country's largest IPO of the year and jumped as much as 21% on its Tokyo debut. The Goldman-backed offering was 25x oversubscribed, and Go is funneling the proceeds into robotaxis -- a Waymo partnership aimed at Japan's worsening driver shortage.
Jun 19, 2026Mobix Labs filed an S-1 registration statement with the SEC, adding a semiconductor name to a 2026 IPO pipeline increasingly stocked with companies tied to the AI and connectivity buildout. The filing is an early step that signals confidence chip-sector stories can find public-market demand in the current window.
Jun 18, 2026Bleichroeder Acquisition Corp. III filed an S-1 with the SEC for a new blank-check IPO, the latest in a string of SPAC filings testing whether the structure can return on disciplined terms. After the 2021 boom-and-bust, sponsors are betting a healthier IPO tape gives blank-check vehicles a second life.
Jun 18, 2026Standard Nuclear filed an S-1 registration statement with the SEC, moving to tap public markets as demand for advanced nuclear fuel and small modular reactors surges alongside the AI data-center power crunch. The filing adds a clean-energy name to a pipeline that has been dominated by AI and space.
Jun 18, 2026Morgan Stanley filed amended S-1 registration statements for both a Solana Trust and an Ethereum Trust with the SEC, pushing a blue-chip Wall Street name deeper into spot-crypto products beyond Bitcoin. The filings signal that institutional crypto access is broadening from BTC into the next tier of large-cap tokens.
Jun 18, 2026Standard Nuclear filed an S-1 registration statement with the SEC, pushing a domestic advanced-nuclear-fuel company toward public markets. The filing rides the same AI-power demand wave fueling fusion, and signals that the IPO pipeline is broadening from software into hard-tech energy.
Jun 18, 2026AIM ImmunoTech filed an S-1 with the SEC, adding a clinical-stage biotech name to a public-market pipeline that has been widening past tech into energy and life sciences. Biotech listings have been among the slowest to thaw, so fresh filings are a useful read on whether risk appetite is returning to the sector.
Jun 18, 2026Morgan Stanley filed an amended S-1 for an Ethereum Trust, a single-asset vehicle giving investors regulated exposure to ETH, alongside a parallel Solana Trust filing. The move signals a bulge-bracket bank broadening institutional crypto access beyond Bitcoin into the next tier of digital assets.
Jun 18, 2026Priced at $135, opened at $161, and now up roughly 58% over its first four trading sessions, with a market cap that has overtaken Tesla's. Days after listing, SpaceX is already deploying its new currency on a $60B all-stock bid for Cursor.
Jun 18, 2026Quantum-cybersecurity firm EigenQ is going public through a SPAC merger with Silicon Valley Acquisition Corp at a $3B valuation, raising about $215M. The company cites a $1.1B backlog and 25% revenue growth in 2025 -- a rare deep-tech listing that isn't a pure AI play.
Jun 18, 2026Japanese ride-hailing app GO went public and closed about 10% above its offering price, directing proceeds toward robotaxi development and autonomous-driving partnerships. The debut is a fresh sign the IPO thaw is reaching beyond U.S. mega-caps to international tech with concrete AI roadmaps.
Jun 18, 2026Cardiovascular biotech Kardigan filed an S-1MEF with the SEC -- a short-form registration used to register additional shares immediately before an offering goes effective. The filing signals Kardigan's IPO is imminent, a sign the biotech listing window is creaking back open alongside tech.
Jun 17, 2026Klarna priced its IPO at a $25B valuation, raising $1.2B and reopening the consumer-fintech window that's been shut since 2022. The buy-now-pay-later pioneer is profitable again after a brutal repricing -- and its debut is the real test of whether public markets will pay up for fintech in an AI-dominated tape.
Jun 17, 2026bioAffinity Technologies filed an S-1 as its noninvasive CyPath Lung cancer test, which shows 92% sensitivity in clinical trials, posted nearly 300% year-over-year unit sales growth in April 2026.
Jun 16, 2026SpaceX raised $85.7B across 639M shares in the largest IPO in history, tripling Saudi Aramco's 2019 record. Priced at $135, it opened at $161 and now trades at $178 -- a 32% gain on the offer price that minted billions in day-one paper gains for early employees and secondary-market buyers.
Jun 15, 2026The two most valuable private AI companies -- OpenAI at ~$852B, Anthropic at ~$965B -- have both filed confidentially with the SEC. When they list, all six MANGOS companies will be public.
Jun 10, 2026Research Alliance Corp IV filed for a $75 million IPO of 7.5 million Class A shares, the fourth blank-check company from a sponsor group that has repeatedly targeted healthcare-sector reverse mergers.
Jun 9, 2026Matternet, the FAA type-certified drone delivery platform, completed a reverse merger to go public and raised $33 million in a private placement alongside the transaction, closing May 22 and making it the first publicly reporting company focused exclusively on drone delivery. CEO Andreas Raptopoulos framed 2026 as the inflection point for U.S. drone delivery as the company expands across healthcare, retail and restaurant delivery.
Jun 8, 2026HCW Biologics filed an S-1 for a best-efforts offering of up to $5.6 million, a modest raise reflecting the tighter capital-access conditions many small-cap clinical-stage biotechs still face despite the broader 2026 IPO boom.
Jun 8, 2026Cerebras is the market's clearest bet on AI hardware scarcity -- up 68% since its May debut at $312. The AI chipmaker trades at a premium pricing in years of Nvidia-alternative demand.
May 14, 2026